Vyberte zemi nebo region

Nyní se nacházíte v části Czech Republic (Česky)
Domovská stránka / O nás / Investors / Newsroom

Newsroom

Filtrovat podle:

pátek 28. října 2022

Arjo publishes interim report for the third quarter 2022 and presents updated financial targets for 2023-2025

“Growth in the third quarter was held back mainly by lower critical care rental volumes in the US, and adjusted for this the Group grew organically by almost 5%. We continue to perform well in most major markets, with healthy demand and growth. However, in the US, effects from extensive healthcare staff shortages and a volatile economic climate for...

Legislativa
Tiskové zprávy
Arjo Logo
pátek 21. října 2022

Arjo’s Provizio SEM Scanner Single-Use-Sensors are now also available on the Scottish Drug Tariff

We are delighted to announce the Provizio® SEM Scanner Single-Use-Sensors are now also available on the Scottish Drug Tariff.

Tiskové zprávy
Arjo Logo
čtvrtek 22. září 2022

Invitation to Arjo’s Capital Markets Day on October 28th, 2022

Analysts, institutional investors and media are invited to Arjo’s Capital Markets Day at Epicenter in Stockholm on October 28th. The event will be held in conjunction with the release of the company’s Q3 report 2022. Possibility to join digitally will be offered as well.

Tiskové zprávy
Arjo Logo
pondělí 1. srpna 2022

Arjo’s Provizio SEM Scanner Single-Use-Sensors are now available on the NHS England and Wales Drug Tariff

We are delighted to announce the Provizio® SEM Scanner Single-Use-Sensors are now available on the NHS England and Wales Drug Tariff.

Tiskové zprávy
Arjo Logo
čtvrtek 14. července 2022

Arjo interim report January-June 2022

“Market demand remains healthy and the order book for capital equipment continues to be significantly above last year’s levels. Performance in the quarter is held back by short-term challenges due to postponed sales in patient handling, significantly lower critical care rental volumes in the US compared with last year, and continued supply chain...

Legislativa
Tiskové zprávy
Arjo CEO Joacim Lindoff
čtvrtek 30. června 2022

Arjo announces date for interim report January-June 2022 and conference call

Arjo will issue its interim report for January-June 2022 on Thursday July 14 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Legislativa
Tiskové zprávy
Arjo Logo
pátek 10. června 2022

Arjo adds a sustainability link to existing 600 MEUR revolving credit facility

Arjo has entered into an agreement to add a sustainability link to an existing 600 MEUR revolving credit facility first signed in December 2021. The facility will be tied to Arjo’s Sustainability Framework 2030 and confirms the Group’s dedication to move its position within the sustainability area.

Tiskové zprávy
Arjo Logo
pátek 22. dubna 2022

Resolutions at Arjo’s Annual General Meeting, 22 April 2022

Arjo AB (publ) held the 2022 Annual General Meeting on Friday 22 April. At the Annual General Meeting the following was resolved:

Legislativa
Tiskové zprávy
Arjo Logo
pátek 22. dubna 2022

Arjo interim report January-March 2022

”Demand for our products and solutions remains very high. The Group grew organically by 1.4%, supported by a strong order intake and an order book for capital equipment which is now significantly higher than at the end of the corresponding period last year. The global challenges within supply chain remain, and the organization continues to manage...

Legislativa
Tiskové zprávy
Arjo CEO Joacim Lindoff
čtvrtek 31. března 2022

Arjo announces date of 2022 Q1 report and conference call

Arjo will issue its Q1 report for 2022 on Friday April 22 at 07:00 CEST, followed by a conference call at 08:00 CEST, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Legislativa
Tiskové zprávy
Arjo Logo
čtvrtek 24. března 2022

Arjo publishes its Annual Report for 2021

Arjo’s Annual Report for 2021 is now available on the Group’s website.

Legislativa
Tiskové zprávy
Arjo Logo
úterý 22. března 2022

NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB (PUBL)

The shareholders of Arjo AB (publ), Corporate ID No. 559092-8064, are hereby invited to attend the Annual General Meeting (the “AGM”) on Friday, April 22, 2022 at 11.00 a.m. CEST in Luftkastellet, Utsiktsvägen 10, Malmö, Sweden.

Legislativa
Tiskové zprávy
Arjo Logo
středa 2. března 2022

Arjo stops deliveries to Russia due to the ongoing military invasion of Ukraine

Today Arjo announces that until further notice, the company has stopped all deliveries and production of equipment destined to Russia due to the ongoing Russian invasion of Ukraine. The decision has been taken in line with the powerful international sanctions against Russia.

Tiskové zprávy
Arjo Logo
čtvrtek 3. února 2022

Arjo publishes year-end report January-December 2021

”We deliver our strongest year to date and grow organically by 3.5%. The entire organization has done a fantastic job in supporting healthcare providers while managing the challenges related to the global supply constraints in a very good way. This enables us to improve both our profitability and financial position, and I am happy to be able to...

Legislativa
Tiskové zprávy
Arjo, President and CEO Joacim Lindoff
čtvrtek 13. ledna 2022

Arjo announces date of 2021 year-end report and conference call

Arjo will issue its year-end report for 2021 on Thursday February 3 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Legislativa
Tiskové zprávy
Arjo Logo
Žádné další výsledky nejsou dispozici
Potvrzuji, že jsem se seznámil s definicí odborníka ve smyslu zákona č. 40/1995 Sb. a že jsem tímto odborníkem.

Kliknutím na tlačítko ANO chci pokračovat na tyto webové stránky a výslovně potvrzuji následující:

  • Jsem odborníkem, tedy osobou oprávněnou předepisovat nebo vydávat zdravotnické prostředky nebo diagnostické zdravotnické prostředky in vitro, případně zaměstnancem poskytovatele zdravotnických služeb.
  • Je mi známa definice odborníka, případně vymezení zaměstnance poskytovatele zdravotnických služeb ve smyslu zákona č. 40/1995 Sb.
  • Beru na vědomí, že informace obsažené na těchto webových stránkách nejsou určeny pro laickou veřejnost, ale pouze pro odborníky a zaměstnance poskytovatelů zdravotnických služeb. Dále potvrzuji, že jsou mi známa rizika spojená s návštěvou těchto webových stránek jinou osobou než odborníkem nebo zaměstnancem poskytovatele zdravotnických služeb (např. neporozumění správnému fungování inzerovaných zdravotnických prostředků, nesprávný výběr zdravotnického prostředku nebo nesprávné učinění diagnózy).